LENZ Therapeutics Inc.

NASDAQ: LENZ · Real-Time Price · USD
37.83
-3.08 (-7.53%)
At close: Aug 15, 2025, 3:59 PM
39.27
3.81%
After-hours: Aug 15, 2025, 07:32 PM EDT

LENZ Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-52.4M -47.74M -49.77M -60.81M -73.08M -118.14M -125.42M -126.33M -128.53M -99.88M -102.08M -96.42M -86.33M -77.19M -70.76M -115.37M -102.09M -84.56M
Depreciation & Amortization
90K 89K 58K 37K 827K 2.91M 5.12M 7.34M 8.71M 8.67M 8.35M 6.12M 4.51M 2.55M 746K 867K 312K 212K
Stock-Based Compensation
9.22M 7.97M 6.37M 5.25M 3.56M 2.15M 1.34M 1.2M 708K 519K 377K n/a n/a n/a n/a n/a n/a n/a
Other Working Capital
2.53M -3.27M -8.81M -8.93M -8.74M -3.24M 4.03M 667K -2.7M -6.61M -7.4M -7.18M -5.86M -5.69M -4.32M -3.21M -1.73M 30K
Other Non-Cash Items
-4.71M -4.78M -2.95M -2.33M 7.83M 51.55M 57.51M 66.32M 64.12M 29.3M 29.46M 24.61M 23.84M 14.75M 19.23M 74.14M 68.34M 69.47M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
578K -7.05M -13.09M -13.44M -9.37M -1.69M 6.26M 731K -4.48M -7.58M -7.21M -5.2M -6.6M -3.37M -2.5M -1.89M 2.2M 586K
Operating Cash Flow
-47.22M -51.5M -59.39M -71.28M -70.1M -67.96M -65.1M -66.56M -79.38M -87.81M -87.98M -81.14M -74.34M -66.03M -52.85M -42.53M -28.07M -14.28M
Capital Expenditures
-685K -578K -468K -319K -4.95M -10.42M -10.81M -11.83M -7.93M -3.7M -6.59M -6.55M -9.28M -8.65M -5.74M -5.37M -2.11M -1.35M
Cash Acquisitions
n/a n/a n/a 679K 1.57M 1.9M 1.9M 1.23M 337K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-222.04M -163.75M -130.65M -84.04M -19.41M -19.41M -47.54M -113.25M -179.42M -266.25M -405.52M -339.81M -254.22M -167.39M n/a n/a n/a n/a
Sales Maturities Of Investments
167.11M 121.99M 87.9M 99.45M 145.25M 209.75M 263.43M 297.23M 319.43M 241.93M 170.25M 90M n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a -111.26M -111.26M -111.26M -111.26M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
-55.61M -153.59M -154.48M -95.53M 30.57M 201.18M 226.35M 192.79M 132.41M -28.03M -241.86M -256.37M -263.5M -176.05M -5.74M -5.37M -2.11M -1.35M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a -8K -59K -67K -67K -138K -87K -79K -79K n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
546K 1.55M 119.43M 119.29M 118.73M 117.31M -576K -576K n/a n/a n/a 306K 306K 306K 306K n/a n/a n/a
Financial Cash Flow
56.4M 27.78M 199M 199.01M 169.21M 171.47M 190K 368K 301K 589K 597K 666K 32.62M 251.7M 417.47M 432.27M 415.38M 195.89M
Net Cash Flow
-46.43M -177.31M -14.87M 8.89M 106.36M 281.38M 138.13M 126.6M 53.34M -115.26M -329.25M -338.56M -306.94M 7.91M 199.81M 217.79M 204.95M n/a
Free Cash Flow
-47.9M -52.08M -59.86M -71.6M -75.05M -78.39M -75.91M -78.39M -87.3M -91.52M -94.57M -87.7M -83.62M -74.69M -58.59M -47.9M -30.18M -15.63M